These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25977082)

  • 1. Attention.
    Callahan PM; Terry AV
    Handb Exp Pharmacol; 2015; 228():161-89. PubMed ID: 25977082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive function.
    Talpos J; Shoaib M
    Handb Exp Pharmacol; 2015; 228():191-213. PubMed ID: 25977083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal paradigms to assess cognition with translation to humans.
    Wallace TL; Ballard TM; Glavis-Bloom C
    Handb Exp Pharmacol; 2015; 228():27-57. PubMed ID: 25977079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Part II. Cognitive domains for pharmacological intervention: implications for neuropsychiatric and neurological illnesses.
    Handb Exp Pharmacol; 2015; 228():157-9. PubMed ID: 26317140
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods for delivering and evaluating the efficacy of cognitive enhancement.
    Harvey PD; Keefe RS
    Handb Exp Pharmacol; 2015; 228():5-25. PubMed ID: 25977078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preface to cognitive enhancement.
    Kantak KM; Wettstein JG
    Handb Exp Pharmacol; 2015; 228():v. PubMed ID: 26317138
    [No Abstract]   [Full Text] [Related]  

  • 7. Part 1. Basic approaches and perspectives.
    Handb Exp Pharmacol; 2015; 228():1-3. PubMed ID: 26317139
    [No Abstract]   [Full Text] [Related]  

  • 8. Social cognition.
    Patin A; Hurlemann R
    Handb Exp Pharmacol; 2015; 228():271-303. PubMed ID: 25977087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways relevant to cognition-enhancing drug targets.
    Ménard C; Gaudreau P; Quirion R
    Handb Exp Pharmacol; 2015; 228():59-98. PubMed ID: 25977080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal memory.
    Sumiyoshi T
    Handb Exp Pharmacol; 2015; 228():237-47. PubMed ID: 25977085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declarative memory.
    Riedel WJ; Blokland A
    Handb Exp Pharmacol; 2015; 228():215-36. PubMed ID: 25977084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers.
    Costa V; Lugert S; Jagasia R
    Handb Exp Pharmacol; 2015; 228():99-155. PubMed ID: 25977081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-modulating effects of cognitive enhancers.
    Levin ED; Bushnell PJ; Rezvani AH
    Pharmacol Biochem Behav; 2011 Aug; 99(2):146-54. PubMed ID: 21334367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
    Pedersen CS; Goetghebeur P; Dias R
    J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats.
    Tomlinson A; Grayson B; Marsh S; Harte MK; Barnes SA; Marshall KM; Neill JC
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1371-80. PubMed ID: 24882551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries.
    Nakamura K
    CNS Drug Rev; 2002; 8(1):70-89. PubMed ID: 12070527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive function profile of children with attention deficit hyperactivity disorder.
    Shallice T; Marzocchi GM; Coser S; Del Savio M; Meuter RF; Rumiati RI
    Dev Neuropsychol; 2002; 21(1):43-71. PubMed ID: 12058835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species.
    Bhakta SG; Young JW
    J Neurosci Methods; 2017 Dec; 292():53-60. PubMed ID: 28754432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.
    Mar AC; Nilsson SRO; Gamallo-Lana B; Lei M; Dourado T; Alsiö J; Saksida LM; Bussey TJ; Robbins TW
    Psychopharmacology (Berl); 2017 Oct; 234(19):2837-2857. PubMed ID: 28744563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.